B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ac 480

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ac 480, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lapatinib
2 shared targets
falnidamol
2 shared targets
erlotinib
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
Loading evidence profile...

This evidence profile for Ac 480 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.